This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Immulogic Pharmaceutical Corporation, The University of North Carolina at Chapel Hill. Active years: 1997-2002.
Company Filing History:
4 out of 36 
2 out of 1,325 
Years Active: 1997-2002
Title: David G Klapper: Innovator in Allergy Treatment
Introduction
David G Klapper is a notable inventor based in Chapel Hill, NC (US), recognized for his contributions to the field of allergy treatment. He holds a total of 4 patents, showcasing his innovative approach to addressing protein allergens.
Latest Patents
Klapper's latest patents focus on methods for treating sensitivity to protein allergens using peptides. One significant patent details the use of peptides that include a T cell epitope recognized by a T cell receptor specific for the protein allergen, particularly targeting Antigen E or I of ragweed pollen. This work has revealed that these antigens belong to a family of proteins, with cDNAs encoding the major human allergen of ragweed and peptides derived from it. The patents also disclose methods for treating individuals sensitive to ragweed, highlighting the potential for improved allergy management.
Career Highlights
Throughout his career, Klapper has worked with prominent organizations, including Immunologic Pharmaceutical Corporation and the University of North Carolina at Chapel Hill. His work in these institutions has significantly contributed to advancements in allergy research and treatment.
Collaborations
Klapper has collaborated with notable colleagues such as Bruce L Rogers and Thorunn Rafnar, further enhancing the impact of his research in the field of allergy treatment.
Conclusion
David G Klapper's innovative work in allergy treatment through his patented methods demonstrates his commitment to improving the lives of individuals affected by allergies. His contributions continue to influence the field and pave the way for future advancements.